Schrödinger, Inc. (SDGR)

4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma

Schrodinger Inc (SDGR) Stock Down 4.8% -- Now Undervalued? GF Score: 73/100

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Critical Review: Schrodinger (NASDAQ:SDGR) versus Weave Communications (NYSE:WEAV)

The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrodinger Q2 Earnings Call Highlights

Schrodinger Q2 Earnings Call Highlights

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It

Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5

Schrodinger, Inc. $SDGR Shares Purchased by Amova Asset Management Americas Inc.

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

AMD Is Up 150% This Year But Here Are 5 Overlooked Stocks Betting on What Comes Next

A Look at Schrodinger Inc (SDGR) After 6.6% Decline -- GF Value $26.32 vs Price $16.25